175
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Rate and Predictors of Mortality Among Adults on Antiretroviral Therapy at Debre Markos Referral Hospital, North West Ethiopia

, &
Pages 251-259 | Published online: 02 Mar 2021

References

  • UNAIDS. UNAIDS report on global AIDS epidemics. Tech. Rep. Geneva, Switzerland: UNAIDS; 2017.
  • Woradet S, Chaimay B, Chantutanon S, Phuntara S, Suwanna K. Characteristics and demographic factors affecting mortality among HIV/AIDS patients in the Southern Region of Thailand. Asia J Public Health. 2012;3(3):86–93.
  • amfAR. World AIDS statistics. The foundation for AIDS; 2014.
  • Brooks JT, Kaplan JE, Holmes KK, Benson C, Pau A, Masur H. HIV-associated opportunistic infections—going, going, but not gone: the continued need for prevention and treatment guidelines. Clin Infect Dis. 2009;48(5):609–611. doi:10.1086/596756
  • UNAIDS. AIDS epidemic update. UNAIDS; 2017.
  • WHO. Available from: https://www.afro.who.int/health-topics/hivaids.
  • UNAIDS. UNAIDS country factsheets, Ethiopia; 2016.
  • Dorfman D, Saag MS. Decline in locomotor functions over time in HIV-infected patients. AIDS. 2014;28(10):1531–1532. doi:10.1097/QAD.0000000000000302
  • Kharsany AB, Karim QA. HIV infection and AIDS in Sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10:34. doi:10.2174/1874613601610010034
  • Piot P, Karim SSA, Hecht R, et al. Defeating AIDS—advancing global health. Lancet. 2015;386(9989):171–218. doi:10.1016/S0140-6736(15)60658-4
  • Organization WH. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization; 2016.
  • Egger M, May M, Chêne G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360(9327):119–129. doi:10.1016/S0140-6736(02)09411-4
  • UNAIDS. Global AIDS update. UNAIDS; 2016.
  • Available from: https://sustainabledevelopment.un.org/?menu=1300. Accessed February 18, 2021.
  • Lima VD, Lourenço L, Yip B, Hogg RS, Phillips P, Montaner JS. AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study. Lancet HIV. 2015;2(3):e92–e97. doi:10.1016/S2352-3018(15)00017-X
  • Karim SSA, Karim QA, Baxter C. Antibodies for HIV prevention in young women. Curr Opin HIV AIDS. 2015;10(3):183. doi:10.1097/COH.0000000000000147
  • UNAIDS. Country fact sheet, Ethiopia. UNAIDS; 2016.
  • FMOH E. Ethiopian FMOH national comprehensive HIV prevention, care and treatment training for health care providers; 2017.
  • Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell M-L. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966–971. doi:10.1126/science.1228160
  • Mossong J, Grapsa E, Tanser F, Bärnighausen T, Newell M-L. Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa. AIDS. 2013;27(15):2471. doi:10.1097/01.aids.0000432475.14992.da
  • Nsanzimana S, Remera E, Kanters S, et al. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. Lancet Global Health. 2015;3(3):e169–e177. doi:10.1016/S2214-109X(14)70364-X
  • Reniers G, Slaymaker E, Nakiyingi-Miiro J, et al. Mortality trends in the era of antiretroviral therapy: evidence from the network for analysing longitudinal population based HIV/AIDS data on Africa (ALPHA). AIDS. 2014;28(4):S533. doi:10.1097/QAD.0000000000000496
  • Buse K, Hawkes S. Health in the sustainable development goals: ready for a paradigm shift? Global Health. 2015;11(1):13. doi:10.1186/s12992-015-0098-8
  • Tang Z, Pan SW, Ruan Y, et al. Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study. Sci Rep. 2017;7(1):3129. doi:10.1038/s41598-017-03384-7
  • Kyaw AT, Sawangdee Y, Hunchangsith P, Pattaravanich U. Survival rate and socio-demographic determinants of mortality in adult HIV/AIDS patients on anti-retrovial therapy (ART) in Myanmar: a registry based retrospective cohort study 2005–2015. J Health Res. 2017;31(4):323–331.
  • Poda A, Hema A, Zoungrana J, et al. Mortality of HIV-infected patients on antiretroviral therapy in a large public cohort in West Africa, Burkina Faso: frequency and associated factors. Adv Infect Dis. 2013;3(04):281. doi:10.4236/aid.2013.34043
  • Bhatta L, Klouman E, Deuba K, et al. Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in far-western Region, 2006–2011. BMC Infect Dis. 2013;13(1):604. doi:10.1186/1471-2334-13-604
  • Hambisa MT, Ali A, Dessie Y. Determinants of mortality among HIV positives after initiating antiretroviral therapy in Western Ethiopia: a hospital-based retrospective cohort study. Isrn Aids. 2013;2013:2013. doi:10.1155/2013/491601
  • Tachbele E, Ameni G. Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study. Epidemiol Health. 2016;38:38. doi:10.4178/epih.e2016049
  • Bajpai R, Chaturvedi H, Jayaseelan L, et al. Effects of antiretroviral therapy on the survival of human immunodeficiency virus-positive adult patients in Andhra Pradesh, India: a retrospective cohort study, 2007–2013. J Preventive Med Public Health. 2016;49(6):394. doi:10.3961/jpmph.16.073
  • Bhowmik A, Bhandari S, De R, Guha SK. Predictors of mortality among HIV–infected patients initiating anti retroviral therapy at a tertiary care hospital in Eastern India. Asian Pac J Trop Med. 2012;5(12):986–990. doi:10.1016/S1995-7645(12)60187-4
  • Seyoum D, Degryse J-M, Kifle YG, et al. Risk factors for mortality among adult HIV/AIDS patients following antiretroviral therapy in Southwestern Ethiopia: an assessment through survival models. Int J Environ Res Public Health. 2017;14(3):296. doi:10.3390/ijerph14030296
  • Damtew B, Mengistie B, Alemayehu T. Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia. Pan African Med J. 2015;22(1). doi:10.11604/pamj.2015.22.138.4352
  • Dalhatu I, Onotu D, Odafe S, et al. Outcomes of Nigeria’s HIV/AIDS treatment program for patients initiated on antiretroviral treatment between 2004–2012. PLoS One. 2016;11(11):e0165528. doi:10.1371/journal.pone.0165528
  • Kebebew K, Wencheko E. Survival analysis of HIV-infected patients under antiretroviral treatment at the Armed Forces General Teaching Hospital, Addis Ababa, Ethiopia. Ethiopian J Health Develop. 2012;26(3):186–192.
  • Lee SH, Kim K-H, Lee SG, et al. Causes of death and risk factors for mortality among HIV-infected patients receiving antiretroviral therapy in Korea. J Korean Med Sci. 2013;28(7):990–997. doi:10.3346/jkms.2013.28.7.990
  • Poka-Mayap V, Pefura-Yone EW, Kengne AP, Kuaban C. Mortality and its determinants among patients infected with HIV-1 on antiretroviral therapy in a referral centre in Yaounde, Cameroon: a retrospective cohort study. BMJ Open. 2013;3(7):e003210. doi:10.1136/bmjopen-2013-003210
  • Digaffe T, Seyoum B, Oljirra L. Survival and predictors of mortality among adults on antiretroviral therapy in selected public hospitals in Harar, Eastern Ethiopia. J Trop Dis. 2014;2(148):2. doi:10.4172/2329-891X.1000148
  • Kerkhoff AD, Wood R, Cobelens FG, Gupta-Wright A, Bekker LG, Lawn SD. The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study. BMC Med. 2015;13:70. doi:10.1186/s12916-015-0320-9